Table 1 of Murro, Mol Vis 2021; 27:542-554.


Table 1. Clinical findings of VHL patients.

ID patient ID family Sex Follow-up (months) Age at diagnosis CNS hemangio
blastomas Other tumors Eye BCVA at presentation Number of RCHs Tractional retinal detachment Exudative maculopathy BCVA (last examination) Treatment technique surgery Complications
P1 F1 F 53 24 y n OD 20/20 0 n n 20/20 n n n
              OS 20/20 1 n n 20/20 laser n n
P2 F2 F 128 42 n n OD 20/20 0 n n 20/20 n n n
              OS 20/25 1 n n 20/25 laser Vitrectomy (for FTMH) retinal tear, FTMH
P3 F2 F 126 61 n y OU 20/25 0 n n 20/25 n n n
P4 F2 F 126 6 n n OU 20/20 0 n n 20/20 n n n
P5 F3 M 109 32 y y OD 20/25 3 y n 20/20 cryo+laser episcleral buckle n
              OS 20/20 2 n n 20/20 laser n n
P6 F3 F 6 10 n n OU 20/20 0 n n 20/20 n n n
P7 F3 M 6 7 n n OU 20/20 0 n n 20/20 n n n
P8 F4 M 6 14 y n OD 20/20 4 n n 20/20 laser n n
              OS 20/640 >10 n y 20/640 cryo+laser+IVT n vitreous hemorrhage
P9 F5 F 168 32 y y OD 20/20 0 n n 20/25 n n n
              OS 20/25 >5 y y nlp cryo+laser episcleral buckle chronic retinal detachment, NVG
P10 F6 M 130 37 y y OD 20/400 >10 y n nlp cryo+laser episcleral buckle chronic retinal detachment, NVG
              OS 20/20 0 n n 20/20 n n n
P11 F6 M 24 12 n n OU 20/20 0 n n 20/20 n n n
P12 F6 M 24 10 y n OU 20/20 0 n n 20/20 n n n
P13 F7 F 108 17 n y OU 20/20 0 n n 20/20 n n n
P14 F8 M 24 33 n y OU 20/20 0 n n 20/20 n n n
P15 F9 F 108 50 y y OU 20/25 0 n n 20/25 n n n
P16 F9 M 84 20 n y OU 20/20 0 n n 20/20 n n n
P17 F10 F 180 28 n y OU 20/25 0 n n 20/25 n n n